AngioDynamics Shares Surge on Strong Earnings and Insider Confidence

Medical technology company AngioDynamics is experiencing substantial momentum following the release of its quarterly financial results, which significantly surpassed market expectations. The positive performance has triggered analyst upgrades and a notable display of confidence from the company’s leadership.

For the first quarter of fiscal year 2026, AngioDynamics reported revenue of $75.7 million, comfortably exceeding the $72.7 million forecast. This represents a 12.2 percent increase in net sales compared to the same period last year. The company also outperformed expectations on adjusted earnings per share, reporting a loss of $0.10 per share versus the anticipated loss of $0.12 per share.

The Med Tech division demonstrated particularly strong growth, with revenues surging 26.1 percent year-over-year. Meanwhile, the Med Device segment posted a more moderate 2.3 percent gain. Overall gross... Read more...